Intranasal corticosteroid and antihistamine combinations in the treatment of allergic rhinitis: the role of the novel formulation olopatadine/mometasone furoate.
Erminia RidoloAlessandro BaroneFrancesca NicolettaGiovanni PaolettiEnrico HeflerLuca MalvezziGiorgio Walter CanonicaPublished in: Expert review of clinical immunology (2023)
The evidence provided in the current review clearly supports the use of GSP301 as a novel INCS/INAH with a well-documented efficacy and safety profile in terms of rapid symptom relief and good tolerability.